Promotions & Moves

AB BioTechnologies Appoints Two New Directors

The new executives will lead Quality, Validation, and IT, in addition to Operations and Facilities

AB BioTechnologies, Inc., a privately-held pharmaceutical contract service provider, has appointed two new executives. Bryan Hudson and Ben Lisby have joined the company as director of Quality, Validation, and IT, and director of Operations and Facilities, respectively.    Hudson brings more than 22 years of industry experience to his new responsibilities of leading quality assurance, quality control, validation, and information technology initiatives. In addition, Lisby brings over 18 y...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters